Nkarta, Inc. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 54.35M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2024-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 54.35M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2023-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 54.35M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2022-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 54.35M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-25 | 54.35M shares 10-K · filed 2026-03-25 | 0.00 shares 10-K · filed 2026-03-25 | 0.00 shares 10-K · filed 2026-03-25 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-25 | 54.35M shares 10-K · filed 2026-03-25 | 0.00 shares 10-K · filed 2026-03-25 | 0.00 shares 10-K · filed 2026-03-25 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-26 | 54.35M shares 10-K · filed 2025-03-26 | 0.00 shares 10-K · filed 2025-03-26 | 0.00 shares 10-K · filed 2025-03-26 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 | 54.35M shares 10-K · filed 2024-03-21 | 0.00 shares 10-K · filed 2024-03-21 | 0.00 shares 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | 54.35M shares 10-K · filed 2023-03-16 | 0.00 shares 10-K · filed 2023-03-16 | 0.00 shares 10-K · filed 2023-03-16 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-17 | 54.35M shares 10-K · filed 2022-03-17 | 0.00 shares 10-K · filed 2022-03-17 | 0.00 shares 10-K · filed 2022-03-17 |
| 2020-07-14 | $0.00 10-K · filed 2024-03-21 | 54.35M shares 10-K · filed 2024-03-21 | ||
| 2020-07-01 | $0.00 10-K · filed 2022-03-17 | 54.35M shares 10-K · filed 2022-03-17 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-20 | 54.35M shares 10-Q · filed 2020-08-20 | ||
| 2019-12-31 | $0.00 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 | 0.00 shares 10-K · filed 2021-03-25 |
| 2019-08-26 | $0.00 10-Q · filed 2020-11-12 | 54.35M shares 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |